Title | Type | SJR | H index | Total Docs. (2011) | Total Docs. (3years) | Total Refs. (2011) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2011) | %Female (2011) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 1.699 Q1 | 202 | 430 | 828 | 53487 | 4696 | 823 | 5.48 | 124.39 | 38.00 | |
2 | Current Molecular Pharmacology | journal | 1.689 Q1 | 49 | 18 | 64 | 2266 | 315 | 64 | 5.34 | 125.89 | 36.23 | |
3 | Current Drug Targets | journal | 1.461 Q2 | 119 | 193 | 419 | 21891 | 1600 | 379 | 3.72 | 113.42 | 35.54 | |
4 | Current Gene Therapy | journal | 1.347 Q2 | 80 | 50 | 132 | 6077 | 671 | 123 | 3.90 | 121.54 | 35.43 | |
5 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.341 Q2 | 108 | 114 | 262 | 10207 | 950 | 234 | 3.16 | 89.54 | 33.73 | |
6 | Open Medicinal Chemistry Journal | journal | 0.921 Q2 | 23 | 13 | 7 | 776 | 25 | 6 | 3.57 | 59.69 | 56.00 | |
7 | Mini-Reviews in Medicinal Chemistry | journal | 0.855 | 107 | 108 | 395 | 10227 | 1177 | 393 | 2.84 | 94.69 | 37.46 | |
8 | Infectious Disorders - Drug Targets | journal | 0.778 Q3 | 61 | 48 | 131 | 4761 | 341 | 115 | 2.68 | 99.19 | 30.65 | |
9 | Central Nervous System Agents in Medicinal Chemistry | journal | 0.615 Q3 | 39 | 34 | 96 | 3225 | 195 | 90 | 2.65 | 94.85 | 41.18 | |
10 | Current Computer-Aided Drug Design | journal | 0.531 Q3 | 32 | 32 | 74 | 2728 | 163 | 70 | 1.91 | 85.25 | 31.40 | |
11 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.497 Q3 | 45 | 18 | 97 | 1059 | 156 | 93 | 1.22 | 58.83 | 47.46 | |
12 | Current Pharmaceutical Analysis | journal | 0.417 Q3 | 27 | 37 | 86 | 1517 | 111 | 85 | 1.29 | 41.00 | 42.28 | |
13 | Analytical Cellular Pathology | journal | 0.365 Q4 | 35 | 27 | 25 | 1153 | 27 | 24 | 1.08 | 42.70 | 42.11 | |
14 | Current Pharmacogenomics and Personalized Medicine | journal | 0.291 Q4 | 20 | 30 | 85 | 2789 | 112 | 75 | 1.61 | 92.97 | 41.79 | |
15 | Letters in Drug Design and Discovery | journal | 0.285 Q4 | 37 | 132 | 298 | 3642 | 274 | 298 | 0.94 | 27.59 | 33.46 | |
16 | Current Enzyme Inhibition | journal | 0.183 Q4 | 19 | 25 | 63 | 2002 | 28 | 61 | 0.49 | 80.08 | 39.47 | |
17 | Turkish Journal of Pharmaceutical Sciences | journal | 0.170 Q4 | 22 | 25 | 68 | 649 | 18 | 68 | 0.24 | 25.96 | 46.27 | |
18 | Current Cancer Therapy Reviews | journal | 0.143 Q4 | 17 | 28 | 104 | 3131 | 34 | 102 | 0.35 | 111.82 | 35.44 | |
19 | Frontiers in Drug Design and Discovery | book series | 0.134 Q4 | 9 | 0 | 18 | 0 | 8 | 17 | 0.44 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®